icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Indian officials ‘need to be charged with manslaughter’ over Covid vaccine shortage: Delhi High Court blasts Modi’s government

Indian officials ‘need to be charged with manslaughter’ over Covid vaccine shortage: Delhi High Court blasts Modi’s government
A high court in India has issued a stern warning to federal officials, claiming that some people should be “charged with manslaughter” for failing to realize the “untapped potential” of the state's vaccine manufacturing capacity.

On Wednesday, the Delhi High Court said there was a “tearing emergency” in the country which underlined a great need to fast-track Covid-19 shot approvals and work with the wealth of vaccine manufacturers in India.

“There is such an element of palpable disquiet throughout the country. Everybody wants the vaccine. You have to cut this [process] short and somehow make the vaccine available,” a division bench of Justices Manmohan and Najmi Waziri said.

“What answer will you give for the loss of lives because of [the] lack of vaccines?” the court asked of the government, blasting officials for the mismanagement of India’s vaccine manufacturing capacity. 

Also on rt.com ‘I drink cow urine every day. That is why I do not have Covid right now’ says Indian ruling party politician

The judges added that some people should be charged with manslaughter for the failure to deliver enough vaccines while sitting on “untapped potential” to produce lifesaving jabs.

On Thursday, the Indian government pre-ordered 300 million doses of unapproved Covid-19 vaccine made by domestic drugmaker Biological-E in an attempt to further speed up the country’s inoculation program, which has only managed to fully dose some 4.7% of India’s adults.

In January, Delhi approved Bharat Biotech’s Covaxin jab despite its not having finished phase three trials. The move was widely criticized by medical experts in India.

Also on rt.com India pre-orders 300 million doses of unapproved Covid-19 vaccine by domestic drugmaker Biological-E

Despite being heralded as the ‘pharmacy of the world’, India has struggled to produce as many vaccines as it requires for its population and even cancelled exports amid a deadly spike in domestic cases.

Like this story? Share it with a friend!

Dear readers and commenters,

We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.

Sorry for the inconvenience, and looking forward to your future comments,

RT Team.

Podcasts